Terms: = Gastric cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54 AND Prognosis
2 results:
1. LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma.
Jin Y; Cao J; Cheng H; Hu X
J Chemother; 2023 Nov; 35(7):638-652. PubMed ID: 36797828
[TBL] [Abstract] [Full Text] [Related]
2. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
